PREDNISOLONE Side Effects

6831414-8 | Asthma Prophylaxis, Otitis Media, Pain
on Jun 28, 2010 Female patient from UNITED STATES , child 3 years of age, was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: asthma prophylaxis, otitis media, pain (What is pain?). Prednisolone dosage: . Patient was hospitalized.

6820351-0 | Adrenal Suppression, Blood Pressure Decreased, Dizziness, Mobility Decreased, Withdrawal Syndrome
Patient was taking Prednisolone (View Usage). Patient had the following side effects: adrenal suppression, blood pressure decreased, dizziness (What is dizziness?), mobility decreased, withdrawal syndrome on Jun 25, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 78 years of age, was diagnosed with temporal arteritis and. Prednisolone dosage: . Patient was hospitalized.

6820339-X | Renal Colic
Adverse event was reported on Jun 23, 2010 by a Male patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with prostate cancer metastatic, hypertension, nutritional support (What is nutritional support?), medical diet and. Location: UNITED KINGDOM , weighting 235.0 lb, After Prednisolone was administered, patient had the following side effects: renal colic. During the same period patient was treated with CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), MOXONIDINE (View Moxonidine Review and Moxonidine Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), ALLIUM SATIVUM (View Allium Sativum Review and Allium Sativum Label ), QUININE (View Quinine Review and Quinine Label ), FISH OIL, HYDROGENATED (View Fish Oil, Hydrogenated Review and Fish Oil, Hydrogenated Label ). Patient was hospitalized and became disabled.

6817986-8 | Hypoxia, Pain In Extremity, Pyrexia, Sickle Cell Anaemia, Steroid Withdrawal Syndrome
on Jun 23, 2010 Female patient from UNITED STATES , child 3 years of age, was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: hypoxia, pain in extremity, pyrexia, sickle cell anaemia, steroid withdrawal syndrome. Prednisolone dosage: 2 Mg/kg/day. Patient was hospitalized.


6816863-6 | Hepatic Enzyme Increased
on Jun 23, 2010 Male patient from UNITED KINGDOM , weighting 172.8 lb, was diagnosed with prostate cancer metastatic, hypertension and was treated with Prednisolone (View Usage). Patient had the following side effects: hepatic enzyme increased. Prednisolone dosage: . During the same period patient was treated with ABIRATERONE ACETATE (View Abiraterone Acetate Review and Abiraterone Acetate Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ).

6815763-5 | Adrenal Suppression, Blood Pressure Decreased, Dizziness, Mobility Decreased, Withdrawal Syndrome
Patient was taking Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: adrenal suppression, blood pressure decreased, dizziness (What is dizziness?), mobility decreased, withdrawal syndrome on Jun 28, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 78 years of age, was diagnosed with temporal arteritis, atrial fibrillation (What is atrial fibrillation?), cardiac pacemaker insertion and. Prednisolone dosage: . During the same period patient was treated with ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), CALCICHEW D3 /UNK/ (View Calcichew D3 /unk/ Review and Calcichew D3 /unk/ Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), WARFARIN (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6810569-5 | Serum Sickness
Adverse event was reported on Jun 23, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with autoimmune hepatitis, thrombotic thrombocytopenic purpura and. Location: UNITED KINGDOM , 14 years of age, Patient experienced the following unwanted or unexpected effects: serum sickness. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

6803888-X | Renal Impairment
on Jun 14, 2010 Male patient from UNITED KINGDOM , 63 years of age, was diagnosed with prostate cancer metastatic and was treated with Prednisolone (View Usage). Patient had the following side effects: renal impairment. Prednisolone dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), CP 751871 (View Cp-751871 Review and Cp-751871 Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), ADCAL (View Adcal Review and Adcal Label ). Patient was hospitalized.

6795599-4 | Tumour Lysis Syndrome
on Jun 15, 2010 Male patient from THAILAND , 14 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: tumour lysis syndrome. Prednisolone dosage: 60 Mg/m2, Daily. During the same period patient was treated with VINCRISTINE (1.5 Mg/m2, Unk) (View Vincristine Review and Vincristine Label ), DOXORUBICIN HCL (25 Mg/m2, Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized.

6795448-4 | Tumour Lysis Syndrome
Patient was taking Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: tumour lysis syndrome on Jun 15, 2010 from TURKEY Additional patient health information: Male patient , child 11 years of age, was diagnosed with t-cell type acute leukaemia and. Prednisolone dosage: 0.5 Mg/kg (12 Mg Total). Patient was hospitalized.

6794701-8 | Oedema Peripheral
Adverse event was reported on Jun 21, 2010 by a Male patient taking Prednisolone (View Usage) (Dosage: Unk) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED KINGDOM , 74 years of age, Patient had the following side effects: oedema peripheral. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg, 1x/day) (View Sunitinib Malate Review and Sunitinib Malate Label ). Patient was hospitalized.

6791263-6 | Lymphoproliferative Disorder
on Jun 14, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with immunosuppression and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: lymphoproliferative disorder. Prednisolone dosage: Unk. During the same period patient was treated with METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ).

6791257-0 | Lymphoproliferative Disorder, Oncologic Complication
on Jun 14, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with immunosuppression and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: lymphoproliferative disorder, oncologic complication. Prednisolone dosage: Unk.

6789996-0 | Eye Injury, Wound
Patient was taking Prednisolone (View Usage). Patient had the following side effects: eye injury, wound (What is wound?) on Jun 14, 2010 from SWEDEN Additional patient health information: Female patient , 60 years of age, was diagnosed with polymyalgia rheumatica (What is polymyalgia rheumatica?) and. Prednisolone dosage: 10-15 Mg Daily. During the same period patient was treated with TOBRADEX (View Tobradex Review and Tobradex Label ), MAXIDEX (Unk) (View Maxidex Review and Maxidex Label ).

6786572-0 | Acute Myeloid Leukaemia, Graft Versus Host Disease, Neoplasm Skin, Oesophageal Squamous Cell Carcinoma, Porokeratosis, Sweat Gland Tumour
Adverse event was reported on Jun 11, 2010 by a Male patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with graft versus host disease, teratoma of testis, acute myeloid leukaemia and. Location: UNITED KINGDOM , 32 years of age, After Prednisolone was administered, patient had the following side effects: acute myeloid leukaemia, graft versus host disease, neoplasm skin, oesophageal squamous cell carcinoma, porokeratosis, sweat gland tumour. During the same period patient was treated with BLEOMYCIN (View Bleomycin Review and Bleomycin Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ).

6779065-8 | Transient Ischaemic Attack
on Jun 07, 2010 Male patient from GERMANY , 65 years of age, weighting 187.4 lb, was diagnosed with prostate cancer metastatic, prophylaxis against gastrointestinal ulcer, reflux oesophagitis and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: transient ischaemic attack. Prednisolone dosage: 5 Mg, 2x/day. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg, 1x/day) (View Sunitinib Malate Review and Sunitinib Malate Label ), PANTOPRAZOL (Unk) (View Pantoprazol Review and Pantoprazol Label ), CALCIUM (Unk) (View Calcium Review and Calcium Label ), METOCLOPRAMIDE (Unk) (View Metoclopramide Review and Metoclopramide Label ), IBUPROFEN (Unk) (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6778743-4 | Pulmonary Embolism
on Jun 09, 2010 Male patient from NETHERLANDS , weighting 207.2 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Prednisolone (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Prednisolone dosage: . During the same period patient was treated with SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), ORAL ANTIDIABETIC (View Oral Antidiabetic Review and Oral Antidiabetic Label ). Patient was hospitalized.

6776541-9 | Chills, Infection, Pyelonephritis
Patient was taking Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: chills, infection (What is infection?), pyelonephritis on Jun 02, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, was diagnosed with kidney transplant rejection and. Prednisolone dosage: 10 Mg;qd; 15 Mg;po;qd; 25 Mg;qd. During the same period patient was treated with MYCOPHENOLATE MOFETIL (750 Mg;po;bid; 500 Mg; Po; Bid) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (75 Mg; Po; Bid; 150 Mg; Po; Bid) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6768713-4 | Disseminated Intravascular Coagulation, Multi-organ Failure, Pneumocystis Jiroveci Pneumonia, Pyrexia
Adverse event was reported on Jun 07, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: Once Daily) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 75 years of age, weighting 113.5 lb, Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, multi-organ failure, pneumocystis jiroveci pneumonia, pyrexia. During the same period patient was treated with METHOTREXATE SODIUM (A Week) (View Methotrexate Sodium Review and Methotrexate Sodium Label ), SPLENDIL (Unk) (View Splendil Review and Splendil Label ), SLOW K (Unk) (View Slow-k Review and Slow-k Label ), FOLIAMIN (Unk) (View Foliamin Review and Foliamin Label ), TAKEPRON (Unk) (View Takepron Review and Takepron Label ). Patient was hospitalized.

6768674-8 | Tumour Lysis Syndrome
on May 31, 2010 Female patient from UNITED KINGDOM , child 11 years of age, was diagnosed with t-cell type acute leukaemia and was treated with Prednisolone (View Usage). Patient had the following side effects: tumour lysis syndrome. Prednisolone dosage: 12 Mg, Single. Patient was hospitalized.

6768080-6 | Renal Impairment
on Jun 09, 2010 Male patient from UNITED KINGDOM , 63 years of age, was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: renal impairment. Prednisolone dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6767935-6 | Hepatosplenomegaly, Lymphoproliferative Disorder
Patient was taking Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: hepatosplenomegaly, lymphoproliferative disorder on Jun 04, 2010 from JAPAN Additional patient health information: Female patient , 76 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Prednisolone dosage: .

6767184-1 | Pulmonary Embolism, Therapeutic Agent Toxicity
Adverse event was reported on May 31, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), atrial fibrillation (What is atrial fibrillation?), bronchitis (What is bronchitis?), coronary artery disease (What is coronary artery disease?), osteoporosis (What is osteoporosis?), hypertension and. Location: GERMANY , 77 years of age, weighting 156.5 lb, Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?), therapeutic agent toxicity. During the same period patient was treated with DIGITOXIN (0.07 Mg, Qd) (View Digitoxin Review and Digitoxin Label ), VERAPAMIL (Unk) (View Verapamil Review and Verapamil Label ), AZITHROMYCIN ABZ (Unk) (View Azithromycin Abz Review and Azithromycin Abz Label ), VOLTAREN (Unk) (View Voltaren Review and Voltaren Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), AMBROXOL (Unk) (View Ambroxol Review and Ambroxol Label ), CALCIUM D3 (Unk) (View Calcium D3 Review and Calcium D3 Label ), ESIDRIX (Unk) (View Esidrix Review and Esidrix Label ). Patient was hospitalized.

6767069-0 | Pulmonary Embolism, Therapeutic Agent Toxicity
on May 31, 2010 Female patient from GERMANY , 77 years of age, weighting 156.5 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), atrial fibrillation (What is atrial fibrillation?), bronchitis (What is bronchitis?), hypertension, coronary artery disease (What is coronary artery disease?), thyroid function test abnormal and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?), therapeutic agent toxicity. Prednisolone dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), MTX HEXAL (View Mtx Hexal Review and Mtx Hexal Label ), ESIDRIX (View Esidrix Review and Esidrix Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6767068-9 | Pulmonary Embolism, Therapeutic Agent Toxicity
on May 31, 2010 Female patient from GERMANY , 77 years of age, weighting 156.5 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), atrial fibrillation (What is atrial fibrillation?), bronchitis (What is bronchitis?), hypertension, coronary artery disease (What is coronary artery disease?), thyroid function test abnormal and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?), therapeutic agent toxicity. Prednisolone dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), MTX HEXAL (View Mtx Hexal Review and Mtx Hexal Label ), ESIDRIX (View Esidrix Review and Esidrix Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6766853-7 | Aspergillosis, Thrombocytopenia
Patient was taking Prednisolone (View Usage). Patient had the following side effects: aspergillosis, thrombocytopenia on Jun 01, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, weighting 124.0 lb, was diagnosed with autoimmune hepatitis and. Prednisolone dosage: 50 Mg, Unk.

6764641-9 | Atrophy Of Globe, Eye Infection Fungal, Uveitis
Adverse event was reported on May 26, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with facial pain and. Location: UNITED KINGDOM , 78 years of age, After Prednisolone was administered, patient had the following side effects: atrophy of globe, eye infection fungal, uveitis. Patient was hospitalized and became disabled.

6764360-9 | Pulmonary Embolism, Therapeutic Agent Toxicity
on Jun 01, 2010 Female patient from GERMANY , 77 years of age, weighting 156.5 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), atrial fibrillation (What is atrial fibrillation?), bronchitis (What is bronchitis?), coronary artery disease (What is coronary artery disease?), osteoporosis (What is osteoporosis?), hypertension and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?), therapeutic agent toxicity. Prednisolone dosage: 15 Mg, 1x/day. During the same period patient was treated with VERAPAMIL HCL (240 Mg, 1x/day) (View Verapamil Hcl Review and Verapamil Hcl Label ), VOLTAREN (75 Mg, 2x/day) (View Voltaren Review and Voltaren Label ), DIGITOXIN (0.07 Mg, 1x/day) (View Digitoxin Review and Digitoxin Label ), AZITHROMYCIN (Unk) (View Azithromycin Review and Azithromycin Label ), ACETYLSALICYLIC ACID (100 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), AMBROXOL (15 Mg, 3x/day) (View Ambroxol Review and Ambroxol Label ), CALCIUM D3 ^STADA^ (Unk) (View Calcium D3 ^stada^ Review and Calcium D3 ^stada^ Label ), ESIDRIX (25 Mg, 1x/day) (View Esidrix Review and Esidrix Label ). Patient was hospitalized.

6759470-6 | Arterial Thrombosis Limb, Peripheral Ischaemia
on May 17, 2010 Male patient from FRANCE , 34 years of age, was diagnosed with antiemetic supportive care and was treated with Prednisolone (View Usage). Patient had the following side effects: arterial thrombosis limb, peripheral ischaemia. Prednisolone dosage: }420 Mg. During the same period patient was treated with ETOPOSIDE (100 Mg/m^2/day/5 Day Cycles X 3 Cycles) (View Etoposide Review and Etoposide Label ), CISPLATIN (20 Mg/m^2/day/5 Day Cycles X 3 Cycles) (View Cisplatin Review and Cisplatin Label ), BLEOMYCIN (30 Mg/day/cycle Days 1, 8, And 15) (View Bleomycin Review and Bleomycin Label ).

6759469-X | Abdominal Pain Lower, Blood Pressure Systolic Increased, Dyspnoea Exertional, Glycosuria, Haematuria, Haemoglobin Decreased, Hyperglycaemia, Kidney Infection
Patient was taking Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: abdominal pain lower, blood pressure systolic increased, dyspnoea exertional, glycosuria, haematuria, haemoglobin decreased, hyperglycaemia, kidney infection on May 18, 2010 from NETHERLANDS Additional patient health information: Male patient , 71 years of age, was diagnosed with idiopathic thrombocytopenic purpura and. Prednisolone dosage: 90 Mg Daily, Oral. Patient was hospitalized.

6758111-1 | Abortion Induced, Pulmonary Hypertension
Adverse event was reported on May 24, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with mixed connective tissue disease, heart block congenital and. Location: UNITED KINGDOM , 23 years of age, Patient experienced the following unwanted or unexpected effects: abortion induced, pulmonary hypertension (What is pulmonary hypertension?). During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

6756247-2 | Brain Abscess, Brain Oedema, Coccidioidomycosis, Grand Mal Convulsion, Haematuria, Leukopenia, Loss Of Consciousness, Pyrexia, Pyuria
on May 27, 2010 Male patient from PORTUGAL , 62 years of age, was diagnosed with immunosuppression and was treated with Prednisolone (View Usage). Patient had the following side effects: brain abscess, brain oedema, coccidioidomycosis, grand mal convulsion, haematuria, leukopenia, loss of consciousness, pyrexia, pyuria. Prednisolone dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE 4MG TAB (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ), BASILIXIMAB (View Basiliximab Review and Basiliximab Label ).

6755384-6 | Anal Fistula
on May 25, 2010 Male patient from UNITED KINGDOM , 66 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: anal fistula. Prednisolone dosage: 5 Mg, 2x/day. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg, 1x/day) (View Sunitinib Malate Review and Sunitinib Malate Label ). Patient was hospitalized.

6754948-3 | Aspergillosis, Atrophy Of Globe, Endophthalmitis, Fibrosis, Intraocular Pressure Decreased, Uveitis, Vitritis
Patient was taking Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: aspergillosis, atrophy of globe, endophthalmitis, fibrosis, intraocular pressure decreased, uveitis, vitritis on May 20, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 78 years of age, was diagnosed with temporal arteritis and. Prednisolone dosage: 80 Mg Qd,. Patient was hospitalized and became disabled.

6752628-1 | Diabetic Ketoacidosis, Hepatosplenic T-cell Lymphoma
Adverse event was reported on May 20, 2010 by a Male patient taking Prednisolone (View Usage) (Dosage: 5 Mg, Daily) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED KINGDOM , 31 years of age, Patient had the following side effects: diabetic ketoacidosis, hepatosplenic t-cell lymphoma. During the same period patient was treated with MERCAPTOPURINE (Unk) (View Mercaptopurine Review and Mercaptopurine Label ), AZATHIOPRINE SODIUM (150 Mg, Daily) (View Azathioprine Sodium Review and Azathioprine Sodium Label ), INFLIXIMAB (Unk) (View Infliximab Review and Infliximab Label ), REMICADE (Unk) (View Remicade Review and Remicade Label ). Patient was hospitalized.

6752338-0 | Squamous Cell Carcinoma
on May 18, 2010 Male patient from NETHERLANDS , 47 years of age, was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: squamous cell carcinoma. Prednisolone dosage: 10 Mg, 1x/day. During the same period patient was treated with AZATHIOPRINE (175 Mg, 1x/day) (View Azathioprine Review and Azathioprine Label ).

6751166-X | Pulmonary Fibrosis
on May 20, 2010 Male patient from UNITED KINGDOM , 78 years of age, was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary fibrosis (What is pulmonary fibrosis?). Prednisolone dosage: . During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), SERETIDE (View Seretide Review and Seretide Label ), VENTOLIN (View Ventolin Review and Ventolin Label ).

6745042-6 | Anosmia, Hyposmia
Patient was taking Prednisolone (View Usage). Patient had the following side effects: anosmia, hyposmia on May 14, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 58 years of age, was diagnosed with lymphoma (What is lymphoma?) and. Prednisolone dosage: Unk. During the same period patient was treated with MUSTARGEN (Unk) (View Mustargen Review and Mustargen Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), PROCARBAZINE (Unk) (View Procarbazine Review and Procarbazine Label ), ADRIAMYCIN PFS (Unk) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), BLEOMYCIN (Unk) (View Bleomycin Review and Bleomycin Label ), VINBLASTINE SULFATE (Unk) (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ).

6740658-5 | Disseminated Intravascular Coagulation, Multi-organ Failure, Pneumocystis Jiroveci Pneumonia, Pyrexia
Adverse event was reported on May 13, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: Once Daily) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 75 years of age, weighting 113.5 lb, After Prednisolone was administered, patient had the following side effects: disseminated intravascular coagulation, multi-organ failure, pneumocystis jiroveci pneumonia, pyrexia. During the same period patient was treated with METHOTREXATE SODIUM (A Week) (View Methotrexate Sodium Review and Methotrexate Sodium Label ), SPLENDIL (Unk) (View Splendil Review and Splendil Label ), SLOW K (Unk) (View Slow-k Review and Slow-k Label ), FOLIAMIN (Unk) (View Foliamin Review and Foliamin Label ), TAKEPRON (Unk) (View Takepron Review and Takepron Label ). Patient was hospitalized.

6740617-2 | Acute Respiratory Distress Syndrome, Anaemia, Antiphospholipid Syndrome, Cerebral Infarction, Circulatory Collapse, Endocarditis Noninfective, Hemiplegia, Hypoxia, Multi-organ Failure
on May 17, 2010 Female patient from UNITED KINGDOM , 56 years of age, was diagnosed with systemic lupus erythematosus and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, anaemia, antiphospholipid syndrome, cerebral infarction, circulatory collapse, endocarditis noninfective, hemiplegia, hypoxia, multi-organ failure. Prednisolone dosage: . During the same period patient was treated with AZATHIOPRINE SODIUM (View Azathioprine Sodium Review and Azathioprine Sodium Label ). Patient was hospitalized.

6740337-4 | Acute Respiratory Distress Syndrome, Anaemia, Antiphospholipid Syndrome, Arterial Thrombosis, Cerebral Infarction, Circulatory Collapse, Device Related Infection, Endocarditis Noninfective, Mass
on May 11, 2010 Female patient from UNITED KINGDOM , 56 years of age, was diagnosed with lupus nephritis, systemic lupus erythematosus and was treated with Prednisolone (View Usage). Patient had the following side effects: acute respiratory distress syndrome, anaemia, antiphospholipid syndrome, arterial thrombosis, cerebral infarction, circulatory collapse, device related infection, endocarditis noninfective, mass. Prednisolone dosage: (5 Mg (2d). During the same period patient was treated with AZATHIOPRINE ((50 Mg Qd)) (View Azathioprine Review and Azathioprine Label ). Patient was hospitalized.

6738796-6 | Aspergillosis, Thrombocytopenia
Patient was taking Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: aspergillosis, thrombocytopenia on May 11, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, was diagnosed with autoimmune hepatitis and. Prednisolone dosage: 50 Mg, Unk.

6736263-7 | Epstein-barr Virus Associated Lymphoproliferative Disorder
Adverse event was reported on May 10, 2010 by a Male patient taking Prednisolone (View Usage) (Dosage: 7.5-15 Mg) was diagnosed with dermatomyositis and. Location: UNITED KINGDOM , 67 years of age, Patient experienced the following unwanted or unexpected effects: epstein-barr virus associated lymphoproliferative disorder. During the same period patient was treated with AZATHIOPRINE (150-175 Mg) (View Azathioprine Review and Azathioprine Label ).

6730784-9 | Agitation, Psychotic Disorder, Restlessness
on May 12, 2010 Female patient from GERMANY , 40 years of age, weighting 147.7 lb, was treated with Prednisolone (View Usage). Patient had the following side effects: agitation, psychotic disorder (What is psychotic disorder?), restlessness. Prednisolone dosage: 1 Mg, Qd. During the same period patient was treated with PREDNISOLUT (1 Mg, Qd) (View Prednisolut Review and Prednisolut Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), PERENTEROL /GFR/ (View Perenterol /gfr/ Review and Perenterol /gfr/ Label ), IMUREK /GFR/ (View Imurek /gfr/ Review and Imurek /gfr/ Label ), NOVALGIN /SCH/ (View Novalgin /sch/ Review and Novalgin /sch/ Label ), HYPERICUM HERBA D20 (View Hypericum Herba D20 Review and Hypericum Herba D20 Label ), POVIDONE IODINE (View Povidone Iodine Review and Povidone Iodine Label ).

6726093-4 | Leukoencephalopathy
on May 07, 2010 Female patient from NETHERLANDS , weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: leukoencephalopathy. Prednisolone dosage: . During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CHLORAMBUCIL (View Chlorambucil Review and Chlorambucil Label ).

6725570-X | Leukopenia
Patient was taking Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia on May 04, 2010 from SWEDEN Additional patient health information: Female patient , 75 years of age, was diagnosed with mycosis fungoides and. Prednisolone dosage: 20 Mg Daily. During the same period patient was treated with METHOTREXATE (15 Mg, Weekly) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6725563-2 | Gastrointestinal Haemorrhage
Adverse event was reported on May 04, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: 30 Mg, Unk) was diagnosed with palliative care (What is palliative care?) and. Location: SWEDEN , 84 years of age, Patient had the following side effects: gastrointestinal haemorrhage. During the same period patient was treated with WARAN (Unk) (View Waran Review and Waran Label ), VAGIFEM (Unk) (View Vagifem Review and Vagifem Label ), ATACAND (Unk) (View Atacand Review and Atacand Label ), UK 88,525 (Unk) (View Uk-88,525 Review and Uk-88,525 Label ), NEORECORMON ^BOEHRINGER MANNHEIM^ (Unk) (View Neorecormon ^boehringer Mannheim^ Review and Neorecormon ^boehringer Mannheim^ Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), FELODIPINE (Unk) (View Felodipine Review and Felodipine Label ), MIRTAZAPINE (Unk) (View Mirtazapine Review and Mirtazapine Label ).

6725550-4 | Benign Endocrine Neoplasm
on May 04, 2010 Female patient from SWEDEN , 49 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: benign endocrine neoplasm. Prednisolone dosage: 5 Mg Daily. During the same period patient was treated with ENBREL (50 Mg, Weekly) (View Enbrel Review and Enbrel Label ).

6724089-X | Dyspnoea, Pulmonary Fibrosis
on Apr 30, 2010 Male patient from UNITED KINGDOM , 78 years of age, was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, pulmonary fibrosis (What is pulmonary fibrosis?). Prednisolone dosage: . During the same period patient was treated with TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ).

6723715-9 | B-cell Lymphoma, Lymphoproliferative Disorder
Patient was taking Prednisolone (View Usage). Patient had the following side effects: b-cell lymphoma, lymphoproliferative disorder on May 04, 2010 from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF Additional patient health information: Male patient , 52 years of age, was diagnosed with prophylaxis against transplant rejection and. Prednisolone dosage: 5 Mg, Daily. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (500 Mg, Daily) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ).